Core Viewpoint - 德恩精工's Q1 2025 financial results show improved profitability despite negative net profit, indicating potential for future growth [2][7] Operating Performance - The company achieved total revenue of 124 million yuan in Q1 2025, a year-on-year increase of 5.13% [2] - The net profit attributable to shareholders was -14.02 million yuan, but improved by 31.92% year-on-year [2] - The non-recurring net profit was -17.95 million yuan, with a year-on-year improvement of 23.19% [2] Profitability - Gross margin reached 6.78%, up 57.96% year-on-year, while net margin was -11.94%, an increase of 33.52% year-on-year [3] Cost Control - Total selling, administrative, and financial expenses amounted to 20.63 million yuan, accounting for 16.65% of revenue, a decrease of 9.37% year-on-year [4] Cash Flow and Asset Status - Operating cash flow per share was 0.06 yuan, a significant increase of 317.91% year-on-year [5] - Cash and cash equivalents were 97.06 million yuan, down 26.18% year-on-year, while accounts receivable increased by 7.24% to 107 million yuan [5] - The ratio of cash to current liabilities was only 26.28%, indicating a need for improved cash flow management [5] Debt Situation - Interest-bearing debt was 635 million yuan, a decrease of 7.75% year-on-year, with an interest-bearing asset-liability ratio of 32.74% [6] Dividends and Financing - Since its listing, the company has raised a total of 425 million yuan and distributed dividends totaling 70.40 million yuan, resulting in a dividend-to-financing ratio of 0.17 [7]

Core Insights - The company reported a total revenue of 357 million yuan in Q1 2025, representing a year-on-year growth of 10.01%, despite a net loss of 10.39 million yuan, indicating an improvement in profitability metrics [1] Financial Performance - The gross margin reached 30.04%, an increase of 17.66% year-on-year, while the net margin was -3.15%, reflecting a year-on-year increase of 70.32%, suggesting effective cost control and enhanced product value [2] Cost Control - Total selling, administrative, and financial expenses amounted to 48.81 million yuan, with the expense ratio decreasing from 16.91% to 13.69% year-on-year, a decline of 19.07%, indicating effective expense management [3] Cash Flow and Debt Management - Operating cash flow per share improved from -0.31 yuan to -0.11 yuan, a year-on-year increase of 65.58%, although it remains negative; cash and cash equivalents decreased by 7.73% to 798 million yuan, and accounts receivable fell by 13.20% to 1.741 billion yuan. Interest-bearing debt rose to 1.574 billion yuan, an increase of 2.94%, with a cash to current liabilities ratio of only 60.38%, highlighting ongoing cash flow and debt challenges [4] Business Model and Financing - The company's performance is primarily driven by research and development, with cumulative financing of 1.032 billion yuan and cumulative dividends of 422 million yuan since its listing, resulting in a dividend-to-financing ratio of 0.41, reflecting a balance between R&D investment and shareholder returns [5]

近期钢研纳克（300797）发布2025年一季报，证券之星财报模型分析如下： 经营概况 资本结构与融资分红 钢研纳克的有息负债为1.27亿元，较去年同期大幅增长372.75%，显示出公司在融资方面的积极态度。 自上市以来，公司累计融资总额为2.79亿元，累计分红总额为1.13亿元，分红融资比为0.4，表明公司在 回报股东方面保持了一定的力度。 商业模式与未来发展 公司业绩主要依赖于研发及营销驱动。未来，投资者应密切关注这类驱动力的实际效果以及公司如何应 对现金流和应收账款带来的挑战。 费用控制 公司在费用控制方面也表现出色，销售费用、管理费用、财务费用总计为6739.29万元，三费占营收比 为30.76%，同比下降了3.57个百分点。这说明公司在优化内部管理、降低运营成本方面取得了一定进 展。 资产与现金流状况 尽管盈利能力有所提升，但公司的现金流状况仍需关注。每股经营性现金流为-0.27元，虽然同比改善 了21.68%，但仍为负值。此外，应收账款为3.03亿元，较去年同期增长22.49%，应收账款与利润的比例 达到了208.72%，提示公司可能存在一定的回款压力。 钢研纳克在2025年一季度实现了营业总收入 ...

近期顶固集创(300749)发布2025年一季报，证券之星财报模型分析如下： 经营业绩 顶固集创(300749)在2025年一季度实现了营业总收入2.05亿元，较去年同期下降6.97%。尽管营业收入有 所减少，但公司的归母净利润达到了511.01万元，同比大幅上升155.00%，扣非净利润为-53.16万元，同 比上升95.42%。这表明公司在控制成本方面取得了一定成效。 盈利能力 本报告期内，顶固集创的盈利能力显著提升，毛利率达到21.54%，同比增加了11.08%；净利率为 2.49%，同比增幅高达159.12%。这些数据显示出公司在提高产品附加值和服务质量上的努力。 费用控制 公司在费用控制方面也表现出色，销售费用、管理费用及财务费用总计为4101.58万元，占营收比例为 20.01%，相比去年同期减少了2.61个百分点。 资产与负债 截至本报告期末，顶固集创的货币资金为2.26亿元，同比增长20.26%；应收账款为8164.27万元，同比 减少了39.27%；有息负债则从1.41亿元增加到2.5亿元，增幅为77.46%。 综上所述，虽然顶固集创在2025年一季度实现了盈利增长，但在现金流管理和每股净资 ...

财务概况 近期ST新研(300159)发布了2025年一季报。报告显示，截至本季度末，公司营业总收入为3247.14万 元，同比上升3.93%；归母净利润为-4778.91万元，同比上升26.97%；扣非净利润为-4876.83万元，同比 上升26.4%。尽管净利润亏损有所减少，但公司仍处于亏损状态。 主要财务指标 收入与利润 盈利能力 费用控制 三费占营收比：179.18%，同比减少12.88% 每股指标 近期*ST新研（300159）发布2025年一季报，证券之星财报模型分析如下： 债务状况 公司债务状况亦需关注，具体表现为： 财务费用状况 营业总收入：3247.14万元，同比上升3.93% 归母净利润：-4778.91万元，同比上升26.97% 扣非净利润：-4876.83万元，同比上升26.4% 毛利率：1.08%，同比减少89.71% 净利率：-154.48%，同比增加30.05% 每股净资产：-0.21元，同比减少905.84% 每股经营性现金流：-0.02元，同比减少336.24% 每股收益：-0.03元，同比增加27.23% 货币资金：4.32亿元，同比增加9.42% 应收账款：2.61亿元， ...

近期金运激光（300220）发布2025年一季报，证券之星财报模型分析如下： 业绩概况 金运激光在2025年一季度实现营业总收入5928.5万元，较去年同期下降16.38%；归母净利润为276.99万 元，同比下降11.37%；扣非净利润为70.95万元，同比下降55.79%。这表明公司在该季度的盈利能力有 所减弱。 总结 总体来看，金运激光在2025年一季度的业绩表现较为疲软，尤其是在营业收入、扣非净利润和现金流方 面出现了明显下滑。公司需要特别关注应收账款的管理和现金流的改善，以确保未来的可持续发展。 毛利率：29.11%，同比减少0.55个百分点。 净利率：5.54%，同比增长6.92个百分点。 三费占营收比：18.54%，同比减少3.89个百分点。 每股净资产：0.43元，同比增长2.67%。 每股经营性现金流：-0.14元，同比减少369.92%。 每股收益：0.02元，同比减少11.59%。 应收账款与现金流 本季度，金运激光的应收账款达到3038.67万元，同比增长19.60%，且应收账款占最新年报归母净利润 的比例高达1438.11%，显示出公司在应收账款管理方面存在较大压力。此外，公司的每股 ...

Core Viewpoint - Dong'e Ejiao reported strong revenue and profit growth in Q1 2025, but faced challenges in cash flow management and accounts receivable [2][5][6] Business Overview - In Q1 2025, Dong'e Ejiao achieved total revenue of 1.719 billion yuan, an increase of 18.24% year-on-year; net profit attributable to shareholders reached 425 million yuan, up 20.25% year-on-year; and net profit excluding non-recurring items was 416 million yuan, a rise of 26.69% year-on-year [2] Profitability - The company's gross margin reached 73.62%, an increase of 2.55 percentage points year-on-year; net margin was 24.73%, up 1.66 percentage points year-on-year, indicating effective cost control and enhanced product value [3] Cost Control - Total selling, administrative, and financial expenses amounted to 693 million yuan, accounting for 40.31% of total revenue, a decrease of 2.13 percentage points compared to the same period last year, reflecting progress in cost management [4] Cash Flow and Financial Position - Operating cash flow per share was -0.47 yuan, a significant decrease of 147.63% compared to 0.99 yuan in the same period last year; cash and cash equivalents fell from 6.791 billion yuan to 5.432 billion yuan, a year-on-year decrease of 20.02%; accounts receivable increased from 187 million yuan to 541 million yuan, a rise of 190.08%, indicating challenges in cash flow management and accounts receivable collection [5] Summary - Overall, Dong'e Ejiao demonstrated strong profitability in Q1 2025 but faces pressure in cash flow management and accounts receivable, necessitating close monitoring of future cash flow improvement measures and accounts receivable management [6]

营收与利润 欧克科技在2025年一季度实现了显著的营收增长，营业总收入达到1.99亿元，同比增长58.9%。归母净 利润为4053.36万元，同比增长25.61%。值得注意的是，扣非净利润达到了3595.96万元，同比增长 83.7%，显示出公司在主营业务上的强劲表现。 盈利能力 尽管营收和利润增长显著，但公司的盈利能力指标有所分化。毛利率为36.75%，同比增加了1.63个百分 点；然而，净利率为20.95%，同比下降了18.6%。这表明公司在成本控制方面可能面临一定压力。 费用控制 公司在费用控制方面表现出色，销售费用、管理费用、财务费用总计为1669.12万元，三费占营收比为 8.38%，同比下降了18.19%。这反映了公司在运营效率上的提升。 近期欧克科技（001223）发布2025年一季报，证券之星财报模型分析如下： 现金流与资产负债 公司货币资金为5.53亿元，较去年同期下降26.81%。每股经营性现金流为0.64元，同比下降32.02%。此 外，应收账款为4.37亿元，同比增加60.42%，应收账款的快速增长值得关注。有息负债为1.38亿元。 商业模式与资本结构 公司业绩主要依靠研发及股权融资驱 ...

Performance Overview - The company reported a decline in performance for Q1 2025, with total revenue of 8.437 billion yuan, a year-on-year decrease of 1.87% [1] - The net profit attributable to shareholders was 101 million yuan, down 5.7% year-on-year, while the net profit excluding non-recurring items was 98.678 million yuan, a decrease of 4.54% [1] Profitability Analysis - The company's gross margin stood at 6.0%, a decrease of 6.35 percentage points year-on-year, and the net profit margin was 1.41%, down 5.55 percentage points [2] Expense Control - Total operating expenses (selling, administrative, and financial expenses) amounted to 301 million yuan, with an expense-to-revenue ratio of 3.57%, which is a year-on-year reduction of 12.12% [3] Asset and Cash Flow Situation - The company's cash and cash equivalents were 1.114 billion yuan, a decline of 29.75% compared to 1.586 billion yuan in the same period last year [4] - Operating cash flow per share was -5.11 yuan, a decrease of 39.28% year-on-year, indicating significant challenges in cash flow management [4] Accounts Receivable and Debt Situation - As of the end of the reporting period, accounts receivable amounted to 8.402 billion yuan, an increase of 5.44% year-on-year, with interest-bearing debt at 4.294 billion yuan, down 2.95% [5] - The ratio of accounts receivable to profit was as high as 1598.78%, necessitating close monitoring of collection [5] Business Model and Capital Return - Over its 29 years since listing, the company has raised a total of 2.272 billion yuan and distributed dividends totaling 332 million yuan, resulting in a dividend-to-financing ratio of 0.15 [6] - The company's performance heavily relies on equity financing and marketing efforts, raising questions about the sustainability of this business model [6] Summary - Overall, the company's performance in Q1 2025 was unsatisfactory, particularly in terms of profitability, cash flow management, and accounts receivable, which pose significant risks [7]

近期广济药业（000952）发布2025年一季报，证券之星财报模型分析如下： 现金流与资本结构 现金流方面，虽然每股经营性现金流为-0元，但相较于去年同期的-0.14元已有明显好转，增幅达 98.77%。不过，财报体检工具提示应关注公司的现金流状况，特别是货币资金与流动负债的比例仅为 41.04%，以及近三年经营性现金流均值与流动负债的比例为-3.34%。 此外，公司的有息负债达到15.17亿元，同比增加9.96%，有息资产负债率已升至39.85%，显示出一定的 债务风险。 总结 经营概况 广济药业在2025年一季度实现营业总收入1.48亿元，较去年同期下降17.58%。尽管营业收入有所下滑， 但公司的归母净利润和扣非净利润分别达到-3626.62万元和-3725.15万元，同比分别上升了28.2%和 34.71%。这表明公司在控制成本方面取得了一定成效。 盈利能力分析 从盈利能力来看，广济药业的毛利率为28.95%，同比增加了76.84%，显示出公司在提升产品附加值方 面有所进展。然而，净利率仍处于负数区间，为-27.06%，但相比去年同期也有所改善，同比增幅为 10.83%。 费用控制 值得注意的是，公司 ...